Fe3O4/Salicylic acid nanoparticles behavior on chick CAM vasculature

Journal of Nanoparticle Research

Volumn 15, Issue 8, 2013, Pages

  Mihaiescu, Dan Eduard ^a   Buteică, Alice Sandra ^b   Neamţu, Johny ^b   Istrati, Daniela ^a   Mîndrilă, Ion ^b  

^a UNIVERSITY POLITEHNICA OF BUCHAREST   (Romania)

^b UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Chick CAM model; Iron oxide nanoparticle; Nanoblocker; Salicylic acid

Indexed keywords

BIOCOMPATIBILITY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; IRON METALLOGRAPHY; IRON OXIDES; LIGHT SCATTERING; MAGNETIC FIELD EFFECTS; MAGNETITE; MEDICAL APPLICATIONS; METAL NANOPARTICLES; MICROCIRCULATION; PRECIPITATION (CHEMICAL); SALICYLIC ACID; SYNTHESIS (CHEMICAL);

BIOMEDICAL APPLICATIONS; CAM MODELS; CHICK CHORIOALLANTOIC MEMBRANE; COPRECIPITATION SYNTHESIS; FOURIER TRANSFORM INFRARED SPECTROMETRY; IRON OXIDE NANOPARTICLE; NANOBLOCKER; TARGETED CANCER THERAPY;

MAGNETIC NANOPARTICLES;

IRON OXIDE; MAGNETIC NANOPARTICLE; NANOPARTICLE; SALICYLIC ACID;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; BLOOD FLOW; CHICK; CHORIOALLANTOIS; IN VIVO STUDY; INFRARED SPECTROMETRY; LIGHT SCATTERING; MAGNETIC FIELD; MAGNETISM; MOLECULARLY TARGETED THERAPY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VASCULARIZATION; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84883484405     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1857-1     Document Type: Article

References (38)

1. Baron JA (2009) Aspirin and NSAIDs for the prevention of colorectal cancer. Recent Results Cancer Res 181:223-229
2. Berry CC, Curtis ASG (2003) Functionalisation of magnetic nanoparticles for applications in biomedicine. J Phys D 36:R198-R206
3. Berry CC, Wells S, Charles S, Curtis AS (2003) Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24:4551-4557 (Pubitemid 37013615)
4. Blacklock CJ, Lawrence JR, Wiles D, Malcolm EA, Gibson IH, Kelly CJ et al (2001) Salicylic acid in the serum of subjects not taking aspirin. Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J Clin Pathol 54:553-555 (Pubitemid 32642946)
5. Cheng FY, Su CH, Yang YS, Yeh CS, Tsai CY, Wu CL et al (2005) Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications. Biomaterials 26:729-738 (Pubitemid 39185876)
6. Chomouckaa J, Drbohlavovaa J, Huskab D, Adamb V, Kizekb R, Hubaleka J (2010) Magnetic nanoparticles and targeted drug delivering. Pharmacol Res 62:144-149
7. Cole BF, Logan RF, Halabi S, Benamouzig R, Sandler RS, Grainge MJ et al (2009) Aspirin for the chemoprevention of colorectal adenomas: metaanalysis of the randomized trials. J Natl Cancer I 101:256-266
8. Cole JA, Yang CV, David AE (2011) Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends Biotechnol 29:323-332
9. Faivre D, Schuler D (2008) Magnetic bacteria and magnetosomes. Chem Rev 108:4875-4898
10. Figuerola A, Di Corato R, Manna L, Pellegrino T (2010) From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res 62:126-143
11. Gaur U, Sahoo SK, De TK, Ghosh PC, Maitra A, Ghosh PK (2000) Biodistribution of fluoresceinated dextran using novel, nanoparticles evading reticuloendothelial system. Int J Pharm 202:1-10 (Pubitemid 30466224)
12. Gruttner C, Teller J (1999) New types of silica-fortified magnetic nanoparticles as tools for molecular biology applications. J Magn Magn Mater 194:8-15
13. Gupta AK, Wells S (2004) Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies. IEEE T Nanobiosci 3:66-73
14. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S et al (2000) Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156:1363-1380 (Pubitemid 30660013)
15. Huang HC, Barua S, Sharma G, Dey SK, Rege K (2011) Inorganic nanoparticles for cancer imaging and therapy. J Control Release 155:257-344
16. Ito A, Shinkai M, Honda H, Kobayashi T (2005) Medical application of functionalized magnetic nanoparticles. J Biosci Bioeng 100:1-11 (Pubitemid 41573511)
17. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V (2008) Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 5:316-327 (Pubitemid 351579134)
18. Kayal S, Ramanujan RV (2010) Anti-cancer drug loaded iron gold core-shell nanoparticles (Fe@Au) for magnetic drug targeting. J Nanosci Nanotechnol 10:1-13
19. Laurent S, Dutz S, Häfeli OU, Mahmoudi M (2011) Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci 166:8-23
20. Lu AH, Salabas EL, Schuth F (2007) Magnetic nanoparticles: synthesis, protection, functionalization, and application. Angew Chem Int Edit 46:1222-1244 (Pubitemid 46981367)
21. Luo T, Yan HM, He P, Luo Y, Yang YF, Zheng H (2012) Aspirin use and breast cancer risk: a meta-analysis. Breast Cancer Res Tr 131(2):581-587
22. McCarthy JR, Weissleder R (2008) Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60:1241-1251
23. Medeiros SF, Santos AM, Fessi H, Elaissari A (2011) Stimuli-responsive magnetic particles for biomedical applications. Int J Pharm 403:139-161
24. Neuberger T, Schopf B, Hofmann H, Hofmann M, Vonrechenberg B (2005) Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293:483-496 (Pubitemid 40608969)
25. Paterson JR, Lawrence JR (2001) Salicylic acid: a link between aspirin, diet and the prevention of colorectal cancer. Q J Med 94:445-448 (Pubitemid 32776287)
26. Praetorius NP, Mandal TK (2007) Engineered nanoparticles in cancer therapy. Recent Pat Drug Deliv Formul 1:37-51
27. Purushotham S, Ramanujan RV (2010) Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. Acta Biomater 6:502-510
28. Qianqian O, Lei Z, Shengguo Z, Huijuan G, Junjie H, Yinyin X et al (2012) Self-templated synthesis of bifunctional Fe3O4@MgSiO3 magnetic sub-microspheres for toxic metal ions removal. Chem Eng J 180:121-127
29. Reimer P, Balzer T (2003) Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications. Eur Radiol 13:1266-1276 (Pubitemid 36790627)
30. Satchell SC, Braet F (2009) Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Renal Physiol 296:947-956
31. Schreinmachers DM, Everson RB (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5:138-146 (Pubitemid 24073387)
32. Singh N, Jenkins G, Asadi R, Doak SH (2010) Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. doi: 10.3402/nano.v1i0.5358
33. Sokolov ND (1984) On the mechanism of the broadening of the proton vibrational IR band in weak hydrogen bonds.Double adiabatic approximation. J Mol Liq 29:231-242
34. Spitz GA, Furtado CM, Sola-Penna M, Zancan P (2009) Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem Pharmacol 77:46-53
35. Taupitz M, Schnorr J, Abramjuk C, Wagner S, Pilgrimm H, Hunigen H et al (2000) New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits. J Magn Reson Imaging 12:905-911
36. Taupitz M, Schnorr J, Wagner S, Abramjuk C, Pilgrimm H, Kivelitz D et al (2002) Coronary MR angiography: experimental results with a mono-mer-stabilized blood pool contrast medium. Radiology 222:120-126 (Pubitemid 34031476)
37. Vainio H, Morgan G (1998) Cyclo-oxygenase 2 and breast cancer prevention. BMJ 317:828-830
38. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP et al (1995) Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 55:3752-3756